![](https://investorshub.advfn.com/uicon/61569.png?cb=1621345219)
Sunday, September 18, 2022 12:26:19 PM
https://www.etfdailynews.com/2022/09/17/short-interest-in-belite-bio-inc-nasdaqblte-expands-by-30-1/
Successful Trading is the art of minimizing long term risk and maximizing capital allocation.
Recent BLTE News
- Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japan • GlobeNewswire Inc. • 06/12/2024 06:55:28 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/04/2024 07:17:11 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/30/2024 08:45:22 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/17/2024 03:36:51 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/16/2024 06:23:22 PM
- Belite Bio to Participate in the Benchmark’s 4th Annual Healthcare House Call Investor Conference • GlobeNewswire Inc. • 05/14/2024 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/14/2024 01:57:52 AM
- Belite Bio Reports First-Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/14/2024 01:50:29 AM
- Belite Bio to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference • GlobeNewswire Inc. • 05/13/2024 12:00:00 PM
- Belite Bio to Host Webcast on May 14, 2024, to Discuss First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/08/2024 12:00:00 PM
- Belite Bio to Participate in Key Opinion Leader Webinar to Discuss Unmet Needs In Stargardt Disease (STGD1) and Geographic Atrophy (GA) and Perspectives On Tinlarebant • GlobeNewswire Inc. • 05/06/2024 12:15:00 PM
- Belite Bio Presents Additional Analysis from Phase 2 Study of Tinlarebant in Stargardt Disease at the ARVO Annual Meeting • GlobeNewswire Inc. • 05/06/2024 12:00:00 PM
- Belite Bio Announces Presentation at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting • GlobeNewswire Inc. • 05/01/2024 08:15:00 PM
- Belite Bio Announces $25 Million Registered Direct Offering • GlobeNewswire Inc. • 04/25/2024 11:15:29 PM
- Belite Bio Announces PMDA Submission of Tinlarebant for Stargardt Disease Clinical Trial in Japan • GlobeNewswire Inc. • 03/22/2024 12:00:00 PM
- Belite Bio Announces Availability of Annual Report on Form 20-F Through Company Website • GlobeNewswire Inc. • 03/12/2024 02:28:39 AM
- Belite Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 03/12/2024 01:27:47 AM
- Belite Bio to Host Webcast on March 12, 2024, to Discuss Fourth Quarter and Full Year 2024 Financial Results • GlobeNewswire Inc. • 03/06/2024 01:00:00 PM
- Belite Bio to Participate in the Leerink Partners Global Biopharma Conference • GlobeNewswire Inc. • 03/04/2024 01:00:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/13/2024 02:08:25 AM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/13/2024 01:40:46 AM
- Belite Bio to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference • GlobeNewswire Inc. • 02/07/2024 01:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/28/2023 09:16:26 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/28/2023 09:15:43 PM
- Belite Bio to Participate in the Benchmark Company’s Upcoming Discovery One-on-One Investor Conference • GlobeNewswire Inc. • 11/30/2023 01:00:00 PM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM